In our study, we confirmed that overexpression of BQ could lead to the activation of IL-6/STAT3 pathway (Figure 1), which conferred resistance to tamoxifen in ER+ breast cancer cells (Figure 2). The gene discussed is ESR1; the disease is breast cancer.